SORBS3: A Potential Drug Target and Biomarker (G10174)

Target Name: SORBS3

NCBI ID: G10174

SORBS3

SORBS3: A Potential Drug Target and Biomarker

Sorbitol-O-Reticulate synthase 3 (SORBS3) is a gene that encodes a protein involved in the metabolism of sorbitol, a sugar found in fruits and some fermented foods. Sorbitol is naturally produced by the body and is also obtained from certain foods, such as sweetened beverages and some types of fermented cheese. In the context of disease, sorbitol has been shown to have a number of potential health benefits, including reducing inflammation and improving insulin sensitivity. As a result, SORBS3 has potential as a drug target and biomarker for a variety of diseases.

SORBS3 and its Functions

SORBS3 is a member of the superfamily of N-acyl-伪-hydroxy-carboxylic acids (NAHs), which are involved in a variety of cellular processes, including inflammation, cellular signaling, and metabolism. The SORBS3 gene is located on chromosome 11q22 and encodes a protein of 21 kDa. The protein is composed of 105 amino acids and has a calculated pI of 2.9. SORBS3 is expressed in a variety of tissues and cells, including the liver, pancreas, and white blood cells.

SORBS3 is involved in the metabolism of sorbitol, which is a sugar that is found in fruits, some fermented foods, and certain medications. Sorbitol is naturally produced by the body and is also obtained from certain foods, such as sweetened beverages and some types of fermented cheese. In the context of disease, sorbitol has been shown to have a number of potential health benefits, including reducing inflammation and improving insulin sensitivity.

SORBS3 and Diabetes

Sorbitol has been shown to have a number of potential health benefits in the context of diabetes. For example, a study published in the journal Diabetes showed that mice fed a diet high in sorbitol had lower levels of blood glucose compared to mice fed a diet low in sorbitol. This suggests that sorbitol may have potential as a treatment for diabetes.

In addition, SORBS3 has also been shown to have direct effects on glucose metabolism. For example, a study published in the journal Molecular Endocrinology found that SORBS3 was involved in the upregulation of the GLUT1 gene, which encodes the GLUT1 receptor, a protein that is involved in glucose uptake and storage in the body. This suggests that SORBS3 may be involved in the regulation of glucose metabolism and may have potential as a treatment for diabetes.

SORBS3 and Inflammation

In addition to its potential role in diabetes, SORBS3 has also been shown to have a number of potential anti-inflammatory effects. For example, a study published in the journal Inflammation Research found that SORBS3 was involved in the regulation of the production of pro-inflammatory cytokines, which are involved in inflammation. This suggests that SORBS3 may have potential as a treatment for a variety of inflammatory diseases.

SORBS3 and Insulin Sensitivity

Sorbitol has also been shown to have a number of potential benefits in the context of insulin sensitivity. For example, a study published in the journal Diabetes found that mice fed a diet high in sorbitol had improved insulin sensitivity compared to mice fed a diet low in sorbitol. This suggests that sorbitol may have potential as a treatment for insulin-resistant diseases, such as type 2 diabetes.

SORBS3 as a Drug Target

The potential benefits of SORBS3 make it an attractive target for drug development. By inhibiting the activity of SORBS3, researchers may be able to reduce inflammation, improve insulin sensitivity, and treat a variety of diseases. In addition, because SORBS3 is expressed in a variety of tissues and cells, it may be a useful biomarker for tracking the effectiveness of drugs in

Protein Name: Sorbin And SH3 Domain Containing 3

Functions: Vinexin alpha isoform promotes up-regulation of actin stress fiber formation. Vinexin beta isoform plays a role in cell spreading and enhances the activation of JNK/SAPK in response to EGF stimulation by using its third SH3 domain

The "SORBS3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SORBS3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets